Vanguard Investments Australia
ZBH icon

Vanguard Investments Australia’s Zimmer Biomet ZBH Stock Holding History

Vanguard Investments Australia’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.49M Buy
98,607
+871
+0.9% +$76.4K 0.02% 516
2026
Q1 		$8.84M Buy
+97,736
New +$8.97M 0.03% 490

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Investments Australia's ZBH Position: Q2 2026 in Review

Vanguard Investments Australia increased its Zimmer Biomet (ZBH) stake by 0.89% in Q2 2026, buying an estimated $76.4K and bringing the position to 98,607 shares worth $8.49M. The position accounts for 0.02% of the portfolio, ranked #516.

Vanguard Investments Australia first reported a position in ZBH in Q1 2026 and has held it in 2 quarters since. The position peaked at $8.84M in Q1 2026. 904 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Vanguard Investments Australia held 98,607 shares of Zimmer Biomet worth $8.49M as of Q2 2026.
  • Vanguard Investments Australia bought 871 Zimmer Biomet shares in Q2 2026, an estimated $76.4K.
  • Zimmer Biomet made up 0.02% of Vanguard Investments Australia's portfolio in Q2 2026, its #516 holding.
  • Vanguard Investments Australia first reported a position in Zimmer Biomet in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Investments Australia's Zimmer Biomet position peaked at $8.84M in Q1 2026.
  • 904 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.